000 01290 a2200349 4500
005 20250515195945.0
264 0 _c20100323
008 201003s 0 0 eng d
022 _a1865-8652
024 7 _a10.1007/s12325-009-0075-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAle, Iris
245 0 0 _aSkin tolerability associated with transdermal drug delivery systems: an overview.
_h[electronic resource]
260 _bAdvances in therapy
_cOct 2009
300 _a920-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAdministration, Cutaneous
650 0 4 _aAge Factors
650 0 4 _aDermatitis, Allergic Contact
_xetiology
650 0 4 _aDermatitis, Irritant
_xetiology
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aErythema
_xchemically induced
650 0 4 _aHumans
650 0 4 _aPharmaceutical Preparations
_xadministration & dosage
650 0 4 _aRisk Factors
650 0 4 _aSex Factors
700 1 _aLachapelle, Jean-Marie
700 1 _aMaibach, Howard I
773 0 _tAdvances in therapy
_gvol. 26
_gno. 10
_gp. 920-35
856 4 0 _uhttps://doi.org/10.1007/s12325-009-0075-9
_zAvailable from publisher's website
999 _c19350178
_d19350178